Diagnamed Holdings Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMED.CN research report →
Companywww.diagnamed.com
Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.
- CEO
- John Karagiannidis
- IPO
- 2022
- HQ
- Toronto, BC, CA
Price Chart
Valuation
- Market Cap
- $5.97M
- P/E
- -5.45
- P/S
- 0.00
- P/B
- -27.12
- EV/EBITDA
- -3.99
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 527.45%
- ROIC
- 542.41%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,403,145 · -180.07%
- EPS
- $-0.01 · -138.10%
- Op Income
- $-1,489,643
- FCF YoY
- 24.45%
Performance & Tape
- 52W High
- $0.25
- 52W Low
- $0.03
- 50D MA
- $0.10
- 200D MA
- $0.08
- Beta
- -1.27
- Avg Volume
- 973.44K
Get TickerSpark's AI analysis on DMED.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DMED.CN Coverage
We haven't published any research on DMED.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DMED.CN Report →